Please assess the completion status of the following clinical trial:

Trial Title: Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of multiple myeloma~* Measurable disease~* For non-secretors, measurable protein by Freelite or plasmacytoma~* Asymptomatic disease~Exclusion Criteria:~* POEMS syndrome~* Plasma cell leukemia~* Receiving steroids greater than the equivalent of 10 mg prednisone~* Infection not controlled by antibiotics~* HIV infection~* Known active hepatitis B or C

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TBL 12 (Type: EXPERIMENTAL): TBL 12, sea cucumber, will be administered orally at a dose of 2 units (20 mL each) twice a day until disease progression

Based on this trial design, predict the completion outcome and termination type (if applicable).